Efficacy of combining insulin glulisine with basal insulin glargine in patients with Type 1 diabetes in everyday clinical practice

被引：0
|
作者：
Fiesselmann, A.
Landgraf, W. [1 ]
Schreiber, S. [2 ]
机构：
[1] Sanofi Aventis Deutschland GmbH, Berlin, Germany
[2] Diabet Ctr Schreiber, Quickborn, Germany
来源：
DIABETIC MEDICINE | 2008年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P43
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy of Adding Once-Daily Insulin Glulisine in Japanese Type 2 Diabetes Patients Treated with Insulin Glargine and Sitagliptin
    Takahara, Mitsuyoshi
    Shiraiwa, Toshihiko
    Katakami, Naoto
    Matsuoka, Taka-aki
    Shimomura, Iichiro
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (10) : 633 - 639
  • [22] Insulin dose and weight profiles of pre- and post-meal insulin glulisine in a basal-bolus regimen with insulin glargine in patients with Type 1 diabetes
    Klaff, L
    Rosenstock, J
    Garg, S
    Souhami, E
    Ways, K
    [J]. DIABETOLOGIA, 2004, 47 : A300 - A300
  • [23] Insulin glargine in Type 2 diabetes: an observational study of everyday practice
    Haak, T
    Schreiber, SA
    Schneider, K
    Schweitzer, MA
    [J]. DIABETOLOGIA, 2004, 47 : A268 - A268
  • [24] Evaluation of the long-term efficacy of insulin glargine (LANTUS®) in patients with type 1 diabetes in clinical practice
    Schreiber, S
    Russmann, A
    [J]. DIABETES, 2003, 52 : A456 - A456
  • [25] Insulin glargine in type 2 diabetes: An observational study of everyday practice
    Schreiber, SA
    Schneider, K
    Schweitzer, MA
    [J]. DIABETES, 2004, 53 : A146 - A146
  • [26] Introducing insulin glulisine in patients with Type 2 diabetes treated with insulin glargine in a real life setting
    Rochlitz, H.
    Schaaf, N. S.
    Donaubauer, B.
    [J]. DIABETIC MEDICINE, 2008, 25
  • [27] Insulin degludec in clinical practice: type 1 diabetes patients switched from their basal insulin to insulin degludec
    Blanquez Martinez, David
    Hayon Ponce, Maria
    Caballero Romero, Alvaro
    Diaz Villamarin, Xando
    Nieto Gomez, Pelayo
    Moron Romero, Rocio
    Davila Fajardo, Cristina
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 301 - 302
  • [28] Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus
    Kawamori, R.
    Kadowaki, T.
    Ishii, H.
    Iwasaki, M.
    Iwamoto, Y.
    [J]. DIABETES OBESITY & METABOLISM, 2009, 11 (09): : 891 - 899
  • [29] Efficacy and Safety of a Basal-Bolus Regimen of Basal Insulin Plus Insulin Glulisine in Patients With Type 2 Diabetes: A Pooled Analysis of 5 Clinical Trials
    Dailey, George
    Lin, Jay
    Wang, Edward
    [J]. DIABETES, 2012, 61 : A284 - A284
  • [30] INSULIN GLARGINE UTILIZATION IN REAL-LIFE-EFFICACY OF A REGIMEN BASED ON INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES PREVIOUSLY ON NPH INSULIN IN CLINICAL PRACTICE IN SPAIN
    Delgado, E.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A517 - A517
12345